It has not been shown to induce heterotopic bone formation.
2.
Palovarotene is a drug shown to prevent heterotopic bone formation in animal models of FOP.
3.
The three-phase bone scan may be the most sensitive method of detecting early heterotopic bone formation.
4.
It is not clear exactly what this means, because these patients do not develop heterotopic bone formation.
5.
Another finding, often misinterpreted as early heterotopic bone formation, is an increased ( early ) uptake around the knees or the ankles in a patient with a very recent spinal cord injury.